Display options
Cite
de Jong JW, Bonnier JJ, Huizer T, et al. Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease. Cardiovasc Drugs Ther. 1993;7(4):677-82doi: 10.1007/BF00877821.
de Jong, J. W., Bonnier, J. J., Huizer, T., Ciampricotti, R., & Roelandt, J. R. (1993). Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease. Cardiovascular drugs and therapy, 7(4), 677-82. https://doi.org/10.1007/BF00877821
de Jong, J W, et al. "Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease." Cardiovascular drugs and therapy vol. 7,4 (1993): 677-82. doi: https://doi.org/10.1007/BF00877821
de Jong JW, Bonnier JJ, Huizer T, Ciampricotti R, Roelandt JR. Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease. Cardiovasc Drugs Ther. 1993 Aug;7(4):677-82. doi: 10.1007/BF00877821. PMID: 8241011.
Copy Download .nbib Format: NLM
Share it on

Cardiovasc Drugs Ther. 1993 Aug;7(4):677-82. doi: 10.1007/BF00877821.

Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease.

Cardiovascular drugs and therapy

J W de Jong, J J Bonnier, T Huizer, R Ciampricotti, J R Roelandt

Affiliations

  1. Thoraxcentre, Erasmus University Rotterdam, The Netherlands.

PMID: 8241011 DOI: 10.1007/BF00877821

Abstract

In a double-blind, randomized, placebo-controlled trial, the possible anti-ischemic effect of metoprolol during percutaneous transluminal coronary angioplasty was tested. Electrocardiograms, hemodynamics, and metabolism were studied in 27 patients with a stenosis in the left anterior descending coronary artery. Measurements took place before angioplasty, after each of four 1-minute occlusions and 15 minutes after the last balloon deflation. Patients were randomly given placebo or metoprolol (15 mg as a bolus intravenously, followed by an infusion of 0.04 mg/kg/hr). At the end of the procedure, the rate-pressure product had decreased by 15% (NS) and 23% (p = 0.001) in the placebo and metoprolol groups, respectively, mainly due to similar decreases in heart rate. Metoprolol tended to lower chest pain and reduce precordial ST-segment elevation due to angioplasty, but the effects were not statistically significant. Lactate, hypoxanthine, and urate release immediately after deflation was similar in both groups. Metoprolol reduced arterial plasma hypoxanthine throughout the procedure by about 30% (p < or = 0.02 vs. placebo). Thus, intravenous infusion of metoprolol did not significantly attenuate chest pain and ST-segment elevation, and failed to decrease cardiac lactate and oxypurine release. It did, however, reduce arterial hypoxanthine concentrations during angioplasty, possibly indicating that the beta-blocker inhibits extracardiac ATP catabolism.

References

  1. Circ Res. 1988 Jul;63(1):262-6 - PubMed
  2. Eur J Pharmacol. 1983 Jun 17;90(4):401-9 - PubMed
  3. Acta Med Scand Suppl. 1981;644:43-5 - PubMed
  4. Circulation. 1986 Apr;73(4):727-33 - PubMed
  5. J Mol Cell Cardiol. 1989 Jul;21(7):691-5 - PubMed
  6. Am J Cardiol. 1991 May 1;67(11):946-52 - PubMed
  7. Am J Cardiol. 1989 Mar 7;63(10):45E-51E - PubMed
  8. Am J Physiol. 1984 Aug;247(2 Pt 2):H330-6 - PubMed
  9. Sports Med. 1988 Apr;5(4):209-25 - PubMed
  10. Am J Hypertens. 1991 Feb;4(2 Pt 1):151-8 - PubMed
  11. Biochim Biophys Acta. 1992 Jul 21;1117(1):25-32 - PubMed
  12. Clin Cardiol. 1992 Aug;15(8):591-5 - PubMed
  13. Circulation. 1991 Dec;84(6 Suppl):VI93-100 - PubMed
  14. J Chromatogr. 1986 Aug 22;381(1):168-74 - PubMed
  15. Am J Cardiol. 1986 Dec 1;58(13):1188-94 - PubMed
  16. J Cardiovasc Pharmacol. 1987 Jul;10(1):55-61 - PubMed
  17. Gen Physiol Biophys. 1985 Jun;4(3):257-64 - PubMed
  18. J Cardiovasc Pharmacol. 1990 Jan;15(1):22-8 - PubMed
  19. Circulation. 1986 Apr;73(4):734-9 - PubMed
  20. Am Heart J. 1991 Jun;121(6 Pt 1):1591-9 - PubMed
  21. Br Heart J. 1986 Nov;56(5):400-13 - PubMed
  22. Eur Heart J. 1992 Jan;13(1):28-32 - PubMed
  23. Am J Cardiol. 1990 Jul 15;66(2):145-50 - PubMed
  24. J Clin Pharmacol. 1990 Feb;30(S2):S2-16 - PubMed
  25. J Hypertens Suppl. 1991 Dec;9(7):S31-4 - PubMed
  26. Am Heart J. 1991 May;121(5):1347-52 - PubMed
  27. Clin Pharmacol Ther. 1981 Nov;30(5):611-8 - PubMed
  28. Clin Chim Acta. 1981;115(1):73-84 - PubMed
  29. Circ Res. 1990 Sep;67(3):770-3 - PubMed
  30. J Cardiovasc Pharmacol. 1992;19 Suppl 1:S44-9 - PubMed
  31. Am J Cardiol. 1991 Apr 22;67(10):43B-46B - PubMed

Substances

MeSH terms

Publication Types